子類別 專利 [0/1] 期刊論文 [107/108] 圖書 [0/1] 會議論文/會議摘要 [30/31] 鄰近社群 何英剛(2006-2011) [38/38] 劉誠珍 [37/37] 周文海 [12/12] 林克明(2004-2009) [66/69] 林彥鋒 [38/40] 王先逸(2005-2010) [5/5] 王昀 [61/72] 王聲昌 [56/59] 羅爾維(2004-2012) [39/39] 謝奉勳 [32/43] 陳嘉祥(2009-2013) [62/64] 陳娟瑜(2004-2010) [91/94] 陳慧諴 [52/60] 陳為堅 [58/59] 陶寶綠 [34/36] 魏榮泰(2004-2010) [2/2] 其他 [157/164] 廖定烈(2005-2008) [18/18] 林兆東(2006-2009) [8/8] 社群統計 近3年內發表的文件:28(19.86%) 含全文筆數:137(97.16%) 文件下載次數統計 下載大於0次:137(100.00%) 下載大於100次:120(87.59%) 檔案下載總次數:58006(0.99%) 最後更新時間: 2025-04-27 03:49 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Brain neuronal integrity in Covid-1... The effect of dopamine receptor D1 ... D-amino acid oxidase correlation wi... Explore the role of growth factor F... Neurofilament light chain as a pote... A new hope for multiple system atro... Explore the role of inflammatory pa... More pronounced neuroaxonal integri... Neurofilament light chain level is ... 用於預測、檢測和監測物質使用障礙症及/或感染的方法

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 141. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-02-12	More pronounced neuroaxonal integrity disturbances in methamphetamine-associated persistent psychosis compared to schizophrenia	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i96-i97.
2025-02-12	Explore the role of inflammatory pathway of Tnfr1 in alcohol dependence and the potential to differentiate delirium tremens	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i297-i298.
2025-02-12	A new hope for multiple system atrophy: A translational research of a novel nmdar receptor modulator from preclinical models to patients	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i76-i77.
2025-02-12	Neurofilament light chain as a potential indicator of delirium tremens among patients with alcohol dependence	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):I95-I96.
2025-02-12	Explore the role of growth factor Fgf2 in alcohol dependence	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i97-i98.
2025-02-12	D-amino acid oxidase correlation with neurofilament light chain in covid-infectedpatients	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i127-i128.
2025-02-12	The effect of dopamine receptor D1 (Drd1) gene variants on changes in craving severity during alcohol withdrawal	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i11-i12.
2025-02-12	Brain neuronal integrity in Covid-19 patients in Taiwan	International Journal of Neuropsychopharmacology. 2025 Feb 12;28(Suppl. 1):i130.
2025-02-01	Neurofilament light chain level is associated with lifetime suicidal behaviors	International Journal of Neuropsychopharmacology. 2025 Feb 1;28(2):Article number pyaf003.
2025-01-10	Plasma neurofilament light chain levels are associated with delirium tremens in patients with alcohol use disorder	Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2025 Jan 10;136:Article number 111189.
2024-12	Association of bone turnover markers and craving reduction in patients with alcohol use disorder during withdrawal: Exploring the role of bone-brain axis	Alcohol, Clinical and Experimental Research. 2024 Dec;48(12):2294-2302.
2024-11	Psychometric evaluation of the Chinese version of alcohol relapse risk scale (C-ARRS) in patients with alcohol use disorder	Alcohol. 2024 Nov;120:25-33.
2024-10-21	Plasma leptin levels are lower in females, but not males, with ketamine use disorder	American Journal of Drug and Alcohol Abuse. 2024 Oct 21;Article in Press.
2024-10	Ketamine-dependent patients with persistent psychosis have higher neurofilament light chain levels than patients with schizophrenia	Asian Journal of Psychiatry. 2024 Oct;100:Article number 104167.
2024-08-31	Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: A meta-analysis[Erratum:Transl Psychiatry. 2024 Jul 19;14:Article number 296.]	Translational Psychiatry. 2024 Aug 31;14:Article number 350.
2024-07-19	Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: A meta-analysis	Transl Psychiatry. 2024 Jul 19;14:Article number 296.
2024-06	Classifying Alzheimer's disease and normal subjects using machine learning techniques and genetic-environmental features	Journal of the Formosan Medical Association. 2024 Jun;123(6):701-709.
2024-03	Changes of neurofilament light chain in patients with alcohol dependence following withdrawal and the genetic effect from ALDH2 Polymorphism	European Archives of Psychiatry and Clinical Neuroscience. 2024 Mar;274(2):423-432.
2024-01-04	Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference	Nature Genetics. 2024 Jan 04;56:222-233.
2023-11	The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank	Journal of Neurology. 2023 Nov;270(11):5536-5544.
2023-09-25	Association of neurofilament light chain with the antidepressant effects of low-dose ketamine infusion among patients with treatment-resistant depression	International Journal of Neuropsychopharmacology. 2023 Sep 25;26(9):649-653
2023-07	Cognitive frailty: A prospective observational cohort study from aged 60 to 66	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):254.
2023-07	Biomarkers as potential indicators for substance use disorder patient care	British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):273-273.
2023-06-28	Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies	medRxiv. 2023 Jun 28;Article in Press.
2023-05	Investigating genetic variants for treatment response to selective serotonin reuptake inhibitors in syndromal factors and side effects among patients with depression in Taiwanese Han population	Pharmacogenomics Journal. 2023 May;23(2-3):50-59.

顯示項目1-25 / 141. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目